Text Size:   A+ A- A   •   Text Only
Site Image

DEA Information...
Drug Enforcement Agency
Click here for What's New from the DEA, or here for News Releases.

National Drug Take-Back Initiative
DEA National Drug Take Back Day - April 26, 2014 

Clarification from the DEA 
Clarification from the DEA - 5/3/12 - Controlled Substance Refills
Clarification from the DEA - 11/2/11
Clarification from the DEA - 5/9/11   

Quick Reference Guide

Long Term Care Facilities

Electronic Prescribing of Controlled Substances
March 2008
Changes that may be made to a CII prescription - 
In a recent issue of pharmacist letter it was stated that the DEA would not allow changes by a pharmacist to a CII prescription.  This is not correct.  No change in DEA policy has occurred.  This is the position on changes a pharmacist may make to CII prescriptions as stated in the DEA FAQ information.

Question: What changes may a pharmacist make to a prescription written for a controlled substance? 
Answer: The pharmacist may add the patient’s address or change the patient’s address upon verification. The pharmacist may change or add the dosage form, drug strength, drug quantity, directions for use, or issue date only after consultation with and agreement of the prescribing practitioner. Such consultations and corresponding changes should be noted on the prescription as well as the patient’s medical record. Pharmacists and practitioners must comply with any state/local laws, regulations, or policies prohibiting any of these changes to controlled substance prescriptions.
The majority of changes can be made only after the pharmacist contacts the prescribing practitioner.
After consultation with the prescribing practitioner, the pharmacist is permitted to add or change the dosage form, drug strength, drug quantity, directions for use, and issue date.
The pharmacist is permitted to make information additions that are provided by the patient or bearer, such as the patient’s address, and such additions should be verified.
The pharmacist is never permitted to make changes to the patient’s name, controlled substance prescribed (except for generic substitution permitted by state law) or the prescriber’s signature.